523 related articles for article (PubMed ID: 16470375)
21. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors.
Cho SK; Na DG; Ryoo JW; Roh HG; Moon CH; Byun HS; Kim JH
Korean J Radiol; 2002; 3(3):171-9. PubMed ID: 12271162
[TBL] [Abstract][Full Text] [Related]
22. [Diffusion and perfusion MR imaging in cerebral lymphomas].
Cotton F; Ongolo-Zogo P; Louis-Tisserand G; Streichenberger N; Hermier M; Jouvet A; Hlaihel C; Jouanneau E; Salles G; Froment JC
J Neuroradiol; 2006 Oct; 33(4):220-8. PubMed ID: 17041526
[TBL] [Abstract][Full Text] [Related]
23. Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics.
Bulakbasi N; Kocaoglu M; Sanal TH; Tayfun C
Neuroradiology; 2007 Oct; 49(10):805-12. PubMed ID: 17632714
[TBL] [Abstract][Full Text] [Related]
24. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
[TBL] [Abstract][Full Text] [Related]
25. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
[TBL] [Abstract][Full Text] [Related]
26. Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors.
Bulakbasi N; Kocaoglu M; Farzaliyev A; Tayfun C; Ucoz T; Somuncu I
AJNR Am J Neuroradiol; 2005 Oct; 26(9):2187-99. PubMed ID: 16219821
[TBL] [Abstract][Full Text] [Related]
27. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences.
Tien RD; Felsberg GJ; Friedman H; Brown M; MacFall J
AJR Am J Roentgenol; 1994 Mar; 162(3):671-7. PubMed ID: 8109520
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
[TBL] [Abstract][Full Text] [Related]
29. Minimum apparent diffusion coefficients in the evaluation of brain tumors.
Kitis O; Altay H; Calli C; Yunten N; Akalin T; Yurtseven T
Eur J Radiol; 2005 Sep; 55(3):393-400. PubMed ID: 16129247
[TBL] [Abstract][Full Text] [Related]
30. Grading of Gliomas by Using Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MR Imaging and Diffusion Kurtosis MR Imaging.
Bai Y; Lin Y; Tian J; Shi D; Cheng J; Haacke EM; Hong X; Ma B; Zhou J; Wang M
Radiology; 2016 Feb; 278(2):496-504. PubMed ID: 26230975
[TBL] [Abstract][Full Text] [Related]
31. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
32. The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas.
Hilario A; Ramos A; Perez-Nuñez A; Salvador E; Millan JM; Lagares A; Sepulveda JM; Gonzalez-Leon P; Hernandez-Lain A; Ricoy JR
AJNR Am J Neuroradiol; 2012 Apr; 33(4):701-7. PubMed ID: 22207304
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
[TBL] [Abstract][Full Text] [Related]
35. Perfusion MR imaging in gliomas: comparison with histologic tumor grade.
Lee SJ; Kim JH; Kim YM; Lee GK; Lee EJ; Park IS; Jung JM; Kang KH; Shin T
Korean J Radiol; 2001; 2(1):1-7. PubMed ID: 11752962
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging.
Maia AC; Malheiros SM; da Rocha AJ; Stávale JN; Guimarães IF; Borges LR; Santos AJ; da Silva CJ; de Melo JG; Lanzoni OP; Gabbai AA; Ferraz FA
J Neurosurg; 2004 Dec; 101(6):970-6. PubMed ID: 15597757
[TBL] [Abstract][Full Text] [Related]
37. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
Sentürk S; Oğuz KK; Cila A
Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
[TBL] [Abstract][Full Text] [Related]
38. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
[TBL] [Abstract][Full Text] [Related]
39. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
[TBL] [Abstract][Full Text] [Related]
40. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]